The US Surgical Matrices Market continued to advance in Q318, up +10.3% YoY, fueled by continued rapid adoption of allograft breast matrices and the resurgence of synthetic hernia matrices.

According to BioMedGPS’ SmartTRAK Financial Dashboard, in Q318, the US Surgical Matrices Market grew +10.3% YoY. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted...

Among the many interesting topics covered in the Q318 US Surgical Matrices Market Recap are:

The US market for Hemostats and Sealants accelerated substantially in Q318 vs Q218

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market, with the exception of Pfizer, saw revenue growth in Q318. Leading the way were Baxter, with its integration of the Mallinckrodt portfolio, as well as Ethicon and Integra, while Pfizer posted...

Among the many topics covered in the Q318 US Hemostats and Sealants Market Recap are:

The Hemostats and Sealants Market continues to grow at a steady clip. SmartTRAK projects this market will reach more than $3.5B by 2022E with a five-year CAGR of ~5%.

It’s good news for many, but do you know the real story behind those numbers?

SmartTRAK identifies what’s driving growth in the global Hemostats and Sealants market. In this Market Outlook article, Doug Devens, SmartTRAK's Senior Analyst, Biosurgery, does a deep dive, discussing what’s fueling this growth and reviews the top market trends you need to know for the year ahead.

• Trend #1: Expanding Indications Fuel Increased Adoption of Fibrin Sealants
• Trend #2: Increasing Use of Sealant Patch Products
• Trend #3: New Plant-Based Technologies Gaining Ground
• Trend #4: Biologic Sealants Ready for Bounce Back

DownloadMarket Outlook: Top Trends to Watch in Hemostats and Sealants

SmartTRAK is excited to be attending ACS - the 2018 Clinical Congress of the American College of Surgeons - on October 21-25 in Boston, Mass. 

The US Surgical Matrices Market advanced again in Q218

In Q218, the US Surgical Matrices Market grew +9.5% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted strong growth in Q218...

Among the many topics covered in the Q218 US Surgical Matrices Recap are:

Baxter, Ethicon and Integra lead the way...

Among the many topics covered in the full Q218 Hemostats and Sealants Market Recap are:

• Ethicon Continues to Lead Hemostats and Sealants
• Thrombins Come Back In Hemostats
• Fibrin Continues To Shine In Sealants
• Q218 events in the US Hemostats and Sealants Market

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Hemostats and Sealants Market Recap.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 US Surgical Matrices Market Recap.

The US Surgical Matrices Market advanced again in Q417, reaching sales of $338.2MM, up +6.8% YoY, fueled by double-digit growth in allograft breast matrices and biosynthetics hernia matrices.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Surgical Matrices Market Recap and Financial Dashboard.

Among the many topics covered in the Q417/FY17 US Surgical Matrices Market Recap are:

The US market for Hemostats and Sealants recovered in Q417, up +5.0% YoY, in line with historic growth rates. While biologic sealants continue to lag, every other segment grew, led by absorbable hemostats and fibrin sealants.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 Hemostats & Sealants Market Recap and Financial Dashboard.

As reported in SmartTRAK’s Financial Dashboard, almost every manufacturer competing in the Hemostats and Sealants market saw revenue growth in Q417/FY17, led by Baxter, Ethicon and Cryolife in Q417 and by Baxter and Integra for FY17 ...